drugset / Trial / NCT00783224
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
RandomizedParallel-groupSingle-blindTreatment
Summary
This study was conducted to see if mometasone nasal spray is efficaceous for the treatment of perennial allergic rhinitis. Patients will be randomized to active mometasone, placebo mometasone, active fluticasone, or placebo fluticasone.
Timeline
- Start
- 2005-09
- Primary completion
- 2005-11
- Completion
- 2005-12
Outcome
Missed primary endpoint
registry analysis (unspecified test); Mometasone Furoate Placebo (PLAMF) vs Mometasone Furoate (MF); p = 0.0001; ANCOVA NCT00783224 ↗
Publications
- Results N. Sou et. al; Allergology & Immunology 16(3) page 394-413, (2009.02) -Japanese language journal
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | 200 ug | Intranasal |
| Subject | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |